Screening should not be performed in individuals younger than 55 years with an intermediate risk of PCa nor even to obtain baseline PSA.Men with a family history of PCa and Afro-Americans are at a high risk of developing PCa. This evidence concerns the gene KLK3 and posterior cortical atrophy.